by Jordana Choucair | Feb 11, 2022 | Life Sciences
The Biden administration bought enough of an experimental monoclonal antibody drug from Eli Lilly & Co. to treat 600,000 COVID-19 patients. According to health officials, the treatment to be shipped to states for free if it’s authorized by regulators. The...
by Jordana Choucair | Feb 11, 2022 | Health IT
A new KFF-Epic Research analysis found that telehealth has decreased somewhat from pandemic highs, but current use still represents a much more substantial share of health care than before COVID-19. According to the analysis, 8 percent of all outpatient visits were...
by Jordana Choucair | Feb 11, 2022 | D.C. News
The Senate is expected to officially vote on Robert Califf’s nomination to lead the FDA as early as Tuesday. The planned vote follows a concerted push by the White House in recent weeks to shore up support for Califf, amid growing concerns over the...
by Jordana Choucair | Feb 11, 2022 | D.C. News
President Biden called on the Senate to pass his Build Back Better legislation, which includes provision to reduce prescription drug prices. Biden stated that the package would “bring down the cost for average families” and “will not increase the debt,” which one of...
by Jordana Choucair | Feb 10, 2022 | D.C. News
House and Senate Appropriations Committee leaders announced they have a deal on a “framework” for fiscal year 2022 appropriations. While the Democrats did not mention specific funding levels, Senate Appropriations Chairman Patrick J. Leahy said the deal...
by Jordana Choucair | Feb 10, 2022 | D.C. News
President Biden will renew his call to curb prescription drug costs today during a visit to Virginia. According to White House Press Secretary Jen Psaki, the president will highlight the need to “stop the abuse of American families.” Biden’s remarks...
Recent Comments